Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Claudin-1, a Biomarker of Epithelial-Mesenchymal Transformation, Enhances Lipid Metabolism in Colorectal Cancer Cells to Promote Tumor Metastasis. | J Gene Med | 2025 | 40890958 | PubTator, text mining | PubMed |
| RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn's Disease. | Inflamm Bowel Dis | 2025 | 40876844 | PubTator, text mining | PubMed |
| Molecular profiles of the great obstetrical syndromes reveal common features and dynamic changes in early pregnancy. | Commun Med (Lond) | 2025 | 40855186 | PubTator, text mining | PubMed |
| Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. | Cell Death Discov | 2025 | 40813760 | PubTator, text mining | PubMed |
| AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. | Front Immunol | 2025 | 40808939 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study. | Pathol Res Pract | 2025 | 40774061 | PubTator, text mining | PubMed |
| A new target for the treatment of oral squamous cell carcinoma: Circ_0046336. | Technol Health Care | 2025 | 40760847 | PubTator, text mining | PubMed |
| Network analysis of master regulators associated with invasive phenotypes in multiple myeloma. | Front Cell Dev Biol | 2025 | 40741330 | PubTator, text mining | PubMed |
| LINC01614: A Potential Therapeutic Target in Astrocytoma Progression. | J Cell Mol Med | 2025 | 40735832 | PubTator, text mining | PubMed |
| The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma. | Curr Issues Mol Biol | 2025 | 40728965 | PubTator, text mining | PubMed |
| Single-Cell Transcription Reveals the Fibroblast Heterogeneity and Neural Cells' Significance in Desmoid Fibromatosis. | Cancer Sci | 2025 | 40706632 | PubTator, text mining | PubMed |
| Revealing the significance of tissue-resident memory T cells in lung adenocarcinoma through bioinformatic analysis and experimental validation. | Front Immunol | 2025 | 40642061 | PubTator, text mining | PubMed |
| [Effect of ADAM12, S100A8, and Serum Tumor Markers on Chemotherapy Outcomes and Prognosis in Patients With Triple-Negative Breast Cancer]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 40599278 | PubTator, text mining | PubMed |
| ADAM Proteases in Cancer: Biological Roles, Therapeutic Challenges, and Emerging Opportunities. | Cancers (Basel) | 2025 | 40427200 | PubTator, text mining | PubMed |
| Incremental capacity analysis of battery under dynamic load conditions. | MethodsX | 2025 | 40337556 | PubTator, text mining | PubMed |
| ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway. | Cancer Lett | 2025 | 40180114 | PubTator, text mining | PubMed |
| MeCP2 promotes keloid progression by regulating ADAM12 expression and Wnt/β-catenin pathway. | Arch Dermatol Res | 2025 | 40119949 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma. | Sci Rep | 2025 | 39984619 | PubTator, text mining | PubMed |
| Molecular mechanisms of recombinant proteins PTTG1IP, ADAM12, PAPSS1, and MYO1B and their effects on wound repair induced by tendon exposure: Analysis of key genes. | Int J Biol Macromol | 2025 | 39978508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=4